Compound | Substituents | Inhibition Rate %a | IC50 (μM)b | ||
HeLa | BGC-823 | HeLa | BGC-823 | ||
43 | X=F, Y=H, R=3’-Cl | 46.9 | 77.5 | 17.29 | 3.63 |
44 | X=F, Y=H, R=4’-Cl | 40.3 | 63.1 | 20.39 | 7.83 |
45 | X=F, Y=H, R=3’-F | 37.0 | 65.3 | 19.82 | 9.10 |
46 | X=F, Y=H, R=4’-F | 20.4 | 49.5 | 43.25 | 11.10 |
47 | X=F, Y=H, R=3’-Cl, 4’-Cl | 40.8 | 56.9 | 36.69 | 8.29 |
48 | X=F, Y=H, R=3’-Cl, 4’-F | 46.8 | 67.5 | 10.18 | 8.32 |
49 | X=F, Y=H, R=4’-CH3 | 41.7 | 59.4 | 18.9 | 7.08 |
50 | X=F, Y=H, R=4’-OCH3 | 36.1 | 35.1 | 55.76 | 21.61 |
51 | X=H, Y=OCH3, R=3’-Cl | 35.3 | 19.5 | 66.69 | >10 |
52 | X=H, Y=OCH3, R=4’-Cl | 31.5 | 13.1 | >10 | >10 |
53 | X=H, Y =OCH3,R=3’-F | 31.9 | 48.1 | 75.87 | 11.67 |
54 | X=H, Y=OCH3,R=4’-F | 18.9 | 37.5 | >10 | 46.41 |
55 | X=H, Y=OCH3, R=3’-Cl, 4’-Cl | 30.8 | 48.7 | 45.87 | 11.45 |
56 | X=H, Y=OCH3, R=3’-Cl, 4’-F | 37.2 | 20.2 | 45.84 | >10 |
57 | X=H, Y=OCH3, R=4’-CH3 | 30.5 | 31.1 | 99.54 | 61.52 |
58 | X=H, Y=OCH3, R=4’-OCH3 | 21.9 | 32.0 | >10 | 74.60 |
59 | X=H, Y=OCH3, R=4’-CH(CH3)2 | 59.1 | 78.4 | 7.15 | 4.65 |
60 | X=H, Y=OCH3, R=3’-Cl, 4’-CH3 | 32.7 | 24.5 | 71.26 | >10 |
61 | X=H, Y=OCH3, R=2’-F, 3’-F,4’-F | 32.5 | 27.6 | 57.88 | >10 |
62 | X=H, Y=OCH3, R=4’-NO2 | 35.8 | 36.8 | 13.48 | >10 |
63 | X=H, Y=OCH3, R=4’-OH | 32.7 | 25.6 | 3.58 | >10 |
64 | X=H, Y=OCH3, R=3’-CN | 28.6 | 16.0 | 30.61 | >10 |
Gefitinib |
| 42.6 | 46.0 | 17.12 | 19.27 |